HOOKIPA Pharma Inc.

NASDAQ:HOOK

1.895 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q12019 Q42019 Q32019 Q22019 Q12018 Q42018 Q32018 Q22018 Q1
Revenue 4.7031.2936.5997.4076.8672.6793.1767.8282.232.7461.4453.8953.8745.3785.3015.1634.046.6853.6963.6182.0384.0512.2355.081.90.6490
Cost of Revenue 00.1560.641.2780.4870.8660.9210.9040.760.861.0781.22820.69819.57220.16413.46416.00911.56411.52611.17911.02513.92910.1794.6156.176.2114.969
Gross Profit 4.7031.13435.9596.1296.381.8132.2556.9241.471.8860.3672.667-16.824-14.194-14.863-8.301-11.969-4.879-7.83-7.561-8.987-9.878-7.9440.465-4.27-5.562-4.969
Gross Profit Ratio 10.8790.9830.8270.9290.6770.710.8850.6590.6870.2540.685-4.343-2.639-2.804-1.608-2.963-0.73-2.119-2.09-4.41-2.438-3.5540.092-2.247-8.570
Reseach & Development Expenses 15.56519.74920.16821.16224.62519.70620.93117.59218.28616.14716.6222.41920.69819.57220.16415.68816.00911.56411.52611.17911.02513.92910.1794.6156.176.2114.969
General & Administrative Expenses 6.7323.9454.0564.3744.9124.4454.9023.8244.9375.0264.9723.5234.3425.0954.3094.6694.4374.3474.6295.6644.5893.7512.7112.6691.2821.4131.48
Selling & Marketing Expenses 00-0.64-1.27800000000000000000000000
SG&A 6.7323.9453.4163.0964.9124.4454.9023.8244.9375.0264.9723.5234.3425.0954.3094.6694.4374.3474.6295.6644.5893.7512.7112.6691.2821.4131.48
Other Expenses 1.05-0.102-0.2851.342-0.8330.025-0.22-1.285-2.081-1.958-1.887-1.495-1.133-0.158-0.0581.4570.9940.646-0.024-0.0910.604-0.1950.2830.1140.033-0.0360.022
Operating Expenses 22.29723.59223.58424.25829.53721.93425.83321.41621.14219.21519.70525.94222.55322.16222.26920.35718.44914.31614.68316.84314.35616.13611.6986.8895.696.244.378
Operating Income -18.644-22.45812.375-18.129-22.67-21.472-22.657-13.588-20.993-18.427-20.147-22.047-21.166-19.289-19.172-15.194-16.406-9.226-12.459-13.225-13.576-13.629-10.655-2.204-5.552-6.975-6.449
Operating Income Ratio -3.964-17.4090.338-2.448-3.301-8.015-7.134-1.736-9.414-6.71-13.943-5.66-5.464-3.587-3.617-2.943-4.061-1.38-3.371-3.655-6.661-3.364-4.767-0.434-2.922-10.7470
Total Other Income Expenses Net 4.8033.3632.0086.2413.6043.4563.1821.5062.7132.0722.1790.8121.1272.1361.9342.722.8172.1341.5332.8722.21.651.3260.3091.6011.1571.9
Income Before Tax -13.841-19.09514.383-24.654-19.066-18.016-19.68-12.311-18.28-16.355-17.968-21.235-20.039-17.153-17.238-12.475-13.589-7.092-10.926-10.244-11.376-11.979-9.329-1.895-3.951-5.818-4.549
Income Before Tax Ratio -2.943-14.8020.393-3.328-2.776-6.725-6.196-1.573-8.197-5.956-12.435-5.452-5.173-3.189-3.252-2.416-3.364-1.061-2.956-2.831-5.582-2.957-4.174-0.373-2.079-8.9650
Income Tax Expense 000.5970.164-0.4870.1220.2050.229-2.7130.001-2.179-0.0020.0010.060.161-3.8891.1880.8120.203-0.1090.0090.10.496-0.0030.0020.0010.024
Net Income -13.841-19.09514.383-24.818-19.066-18.016-19.68-12.311-18.28-16.356-17.968-21.235-20.04-17.153-17.238-12.474-13.589-7.092-10.926-10.244-11.385-12.079-9.329-1.892-3.953-5.819-4.573
Net Income Ratio -2.943-14.8020.393-3.351-2.776-6.725-6.196-1.573-8.197-5.956-12.435-5.452-5.173-3.189-3.252-2.416-3.364-1.061-2.956-2.831-5.586-2.982-4.174-0.372-2.081-8.9660
EPS -1.1-1.521.1-2.51-1.73-2.18-2.73-2.25-0.25-0.23-0.4-0.65-0.61-0.52-0.53-0.46-0.53-0.28-0.43-0.4-0.45-0.63-0.37-0.12-0.24-0.36-0.28
EPS Diluted -1.1-1.521.1-2.51-1.73-2.18-2.73-2.25-0.25-0.23-0.4-0.65-0.61-0.52-0.53-0.46-0.53-0.28-0.43-0.4-0.45-0.63-0.37-0.12-0.24-0.36-0.28
EBITDA -13.141-18.38113.015-23.327-18.53-17.053-18.432-11.07-17.415-15.264-16.647-19.78-18.714-15.717-15.916-9.648-12.759-6.448-10.29-13.225-10.383-10.93-8.55-1.517-3.586-5.476-4.216
EBITDA Ratio -2.794-14.2490.356-2.275-3.301-6.365-7.134-1.736-7.809-5.559-11.52-5.66-4.831-2.922-3.002-2.943-3.158-0.965-2.784-3.655-5.095-2.698-3.826-0.299-1.887-8.4380